The biological framework: translational research from bench to clinic

Area of Science:

• Oncology
• Molecular Biology
• Systems Biology

Background:

• Cellular signaling pathways, especially those involving growth factors and their receptors, are fundamental to tumor development, metastasis, and survival against cancer therapies.
• These pathways form complex networks that can adapt to single-agent interventions.
• Targeting these networks is a key focus in modern cancer research and the development of targeted therapies.

Purpose of the Study:

• To explore the intricate nature of growth factor signaling pathways in malignant tumors.
• To discuss novel therapeutic strategies for disrupting these oncogenic networks.
• To frame the understanding and manipulation of these pathways using engineering and mathematical concepts.

Main Methods:

• Review of current research on growth factor signaling in cancer.
• Analysis of the adaptive mechanisms of signaling pathways to therapeutic insults.
• Exploration of novel therapeutic approaches, including immunotherapy, antibody combinations, and drug combinations.

Main Results:

• Growth factor signaling pathways are critical regulators of tumor progression and resistance to therapy.
• Complex signaling networks exhibit resilience to single-target interventions.
• Combination therapies and novel strategies targeting essential network hubs show promise in overcoming resistance and eliminating tumor cells.

Conclusions:

• Targeting complex growth factor signaling networks, particularly through multi-pronged approaches, is a promising strategy for cancer treatment.
• Understanding the network dynamics is essential for designing effective combination therapies.
• Engineering and mathematical frameworks can provide novel insights into disrupting oncogenic signaling.